PT - JOURNAL ARTICLE AU - Mesut Bayraktaroglu AU - Engin Aynaci AU - Pinar Yildiz TI - The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer DP - 2012 Sep 01 TA - European Respiratory Journal PG - P4193 VI - 40 IP - Suppl 56 4099 - http://erj.ersjournals.com/content/40/Suppl_56/P4193.short 4100 - http://erj.ersjournals.com/content/40/Suppl_56/P4193.full SO - Eur Respir J2012 Sep 01; 40 AB - In our study, pathological stage and Eastern Cooperative Oncology Group (ECOG) performance status were assessed in surgically resected non-small cell lung cancer (NSCLC) patients. The aim was to determine the effects of tumor stage and performance status on overall survival and disease-free survival in our cases.METHODS: 148 consecutive patients (mean age 57.9±8.29 years, min 36 max 76) were included in this study. 12 (%8.1) patients were women and 136 (%91.9) were men. Each patient was staged according to the TNM classification.RESULTS: ECOG performance status was related with both mean survival and disease-free survival time (respectively p=0.011 and p=0.044). 148 patients were grouped by using 1997 TNM and 2009 IASLC staging systems. According to survival analysis, disease-free survival was not related with stage but mean survival analysis revealed that stage 3 cases had significantly worse survival compared to stage 1 cases (p=0.005).CONCLUSION: According to our results, survival was significantly worse in stage 3 patients and patients with poor performance status.